DXCM Q1 2021 Earnings — DexCom, Inc. Revenue & Financial Results | Market Cap Arena

DXCMDexCom, Inc.

$27B

Q1 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$505M+24.7% YoY

Gross Profit

$344M68.1% margin

Operating Income

$46M9.1% margin

Net Income

$40M8.0% margin

EPS (Diluted)

$0.14

QoQ Revenue Growth

-11.2%

Cash Flow

Operating Cash Flow

$28M

Free Cash Flow

-$72M

Stock-Based Comp.

$28M

Balance Sheet

Total Assets

$4.4B

Total Liabilities

$2.5B

Stockholders' Equity

$1.9B

Cash & Equivalents

$734M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$505M	$405M	+24.7%
Gross Profit	$344M	$257M	+34.1%
Operating Income	$46M	$34M	+36.6%
Net Income	$40M	$20M	+102.5%

Geographic Segments

UNITED STATES

$381M75%

Non-US

$124M25%